A carregar...
Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
High-dose methotrexate-based chemotherapy has extended survival in patients with primary central nervous system lymphoma (PCNSL). However, although salvage treatment is necessary in recurrent and refractory PCNSL, this has not been standardized. We herein describe the efficacy of a combination of ri...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Yonsei University College of Medicine
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3220260/ https://ncbi.nlm.nih.gov/pubmed/22028172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2011.52.6.1031 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|